Quantcast

MIT Canada launches MED-JET(R) products in Russia after receiving regulatory approval.

April 7, 2011

DENVER, CO, April 7 /PRNewswire/ – Medical International Technology Inc.
(OTCBB: MDLH) www.mitneedlefree.com is pleased to announce its latest achievements in Russia.

Over the past few months, MIT has been working closely with a Russian
distributor to cover its marketing and sales in Russia. The newly
signed distributor agreement and initial order worth approximately
half-a-million dollars in Med-Jet products for the mesotherapy market
is in progress.

Mr Karim Menassa was in Moscow for a sales and marketing kick off
meeting to launch the Med-Jet products into the lucrative cosmetic
market. The meeting was organized by MIT’s Russian distributor and held
at a prestigious Moscow hotel in the presence of over 300 specialists,
in addition to Canadian dignitaries and local and international media.

MIT is delighted to have received the official certification to sell
MED-JET(®) products to a very important market, said MIT President and CEO, Mr
Karim Menassa. This new distributor will help MIT Canada achieve its
business plan, which forecasts multi-million dollars of sales in
different niche markets worldwide within the next 3 to 5 years.

Dr. Francis Bellido, Vice-President and Chief Strategy Officer of MIT
Canada believes that the access to the fast growing Russian cosmetic
market is a tremendous achievement and will serve to open future
markets around the world to MIT’s unique and effective products and
technologies.

Medical International Technology Inc. is proud to continue providing a
safe and effective means to help prevent the spread of deadly diseases
to both humans and animals through the use of the Med-Jet(®) and Agro-Jet(®) needle-free injection system.

About Medical International Technology, Inc. MIT CANADA, with offices in
Montreal, is a subsidiary of Denver, Colorado-based Medical
International Technology, Inc. (MIT USA), which specializes in the
development, production, marketing and sale of needle-free injectors
both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press
release are forward-looking statements that involve certain risks and
uncertainties, including but not limited to risks associated with the
uncertainty of future financial results, additional financing
requirements, development and acquisition of new product lines and
services, government approval processes, the impact of competitive
products or pricing a technological changes, the effect of economic
conditions and other uncertainties, and the risk factors set forth from
time to time in the Company’s SEC reports, including but not limited to
its annual report on Form 10-KSB; its quarterly reports on Forms
10-QSB; and any reports on Form 8-K. Medical International Technology
Inc. takes no obligation to update or correct forward-looking
statements.

SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.


Source: newswire



comments powered by Disqus